Biochemical and biological properties of phospholipases A2 from Bothrops atrox snake venom

Biochemical Pharmacology

Volumn 64, Issue 7, 2002, Pages 1179-1186

  Kanashiro, Milton M ^a   De Escocard, Rita Cássia M ^a   Petretski, Jorge H ^a   Prates, Maura V ^b   Alves, Elias W ^c   Machado, Olga L T ^c   Da Silva, Wilmar Dias ^a   Kipnis, Thereza L ^a  

^a Centro de Biociências e Biotecnologia   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

Author keywords

Edema; Myotoxin; Phospholipase A2; Snake venom

Indexed keywords

BATROXOBIN; CREATINE KINASE; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2; POLYCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL MEMBRANE; CONTROLLED STUDY; DRUG ACTIVITY; EDEMA; ENZYME ISOLATION; HISTOLOGY; IN VITRO STUDY; MAST CELL DEGRANULATION; MOLECULAR WEIGHT; MOUSE; MUSCLE NECROSIS; MYOFILAMENT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEQUENCE HOMOLOGY; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; BOTHROPS; CATALYSIS; CREATINE KINASE; CROTALID VENOMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUSCLE, SMOOTH; PHOSPHOLIPASES A; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0036774259     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01288-1     Document Type: Article

References (30)

1. 2s. In: Tu AT, editor. Handbook of Natural Toxins. New York: Marcel Dekker, 1991. p. 107-45.
2. 2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488:2000;1-19.
3. 2: Basic and Clinical Aspects in Inflammatory Diseases. Basel, Switzerland: S. Karger AG, 1997. p. 1-10.
4. 2 Enzymes: Structure, Function and Mechanism. Chichester: John Wiley, 1997. p. 1-28.
5. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 267:1992;22645-22657.
6. Lomonte B.J.M. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon. 27:1989;725-733.
7. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
8. Bozzo S., Retamal C. Gel-perfect: geles unidimensionales, un nuevo método densitométrico para computadores personales. Arch. Biol. Med. Exp. (Santiago). 24:1991;181-184.
9. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
10. Köhler J., Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
11. Yamakawa M, Nozaki M, Hokama Z. Fractionation of Sakishima-habu (Trimeresurus elegans) venom and lethal, hemorrhagic and edema-forming activities of the fractions. In: Osaka A, Hayashi K, Sawai Y, editors. Animal, Plant and Microbial Toxins, vol. 1. New York: Plenum Press, 1976. p. 97-109.
12. Lôbo de Araújo A., Souza A.O., Cruz-Höfling M.A., Flores C.A., Bon C. Bothrops lanceolatus (Fer de lance) venom induces oedema formation and increases vascular permeability in the mouse hind paw. Toxicon. 38:2000;209-221.
13. Mota I., Dias da Silva W. Antigen induced damage to isolated sensitized mast cells. Nature. 186:1960;145-146.
14. 2. Arch. Biochem. Biophys. 284:1991;352-359.
15. 2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding. J. Biol. Chem. 259:1984;13839-13843.
16. Perbandt M., Wilson J.C., Eschenburg S., Mancheva I., Aleksiev B., Genov N., Willingmann P., Weber W., Singh T.P., Betzel Ch. Crystal structure of vipoxin at 2.0 Å: an example of regulation of a toxic function generated by molecular evolution. FEBS Lett. 412:1997;573-577.
17. 2's may imply gene duplications. J. Mol. Evol. 41:1995;174-179.
18. 2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor. Arch. Biochem. Biophys. 267:1999;26-32.
19. Hendon R.A., Fraenkel-Conrat H. Biological roles of the two components of crotoxin. Proc. Natl. Acad. Sci. U.S.A. 68:1971;1560-1563.
20. Rubsamen K., Breithaupt H., Habermann E. Biochemistry and pharmacology of the crotoxin complex. I. Subfractionation and recombination of the crotoxin complex. Naunyn Schmiedebergs Arch. Pharmacol. 270:1971;274-288.
21. Slotta K.H., Fraenkel-Conrat H.L. Schlangengifte III Mitteilung: Reinigung und Krystallisation des Klapperschlangen-Giftes. Ber. Dt. Chem. 71:1938;1076-1081.
22. 2 proteins. Toxicon. 37:1999;411-415.
23. Mebs D., Ownby C.L. Myotoxic components of snake venoms: their biochemical and biological activities. Pharmacol. Ther. 48:1990;223-236.
24. 2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
25. 2. Toxicon. 19:1981;705-720.
26. 2: a potent inhibitor of platelet aggregation. Thromb. Res. 70:1993;471-481.
27. 2 homologues: dissociation between enzymatic and biological activities. Eur. J. Pharmacol. 343:1998;257-263.
28. Lomonte B., Tarkowski A., Hanson L.A. Host response to Bothrops asper snake venom, analysis of edema formation, inflammatory cells and cytokine release in mouse model. Inflammation. 17:1993;93-105.
29. 2? Biochemie. 82:2000;815-831.
30. 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family. Biochem. Pharmacol. 47:1994;1509-1518.